FDA Inspection 1046306 — HCSC-Blood Center
The FDA completed an inspection of HCSC-Blood Center on March 15, 2018 in Bethlehem, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- March 15, 2018
- Fiscal Year
- 2018
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Bethlehem, PA (United States)